Sectors

Telecoms are the connecting tissue of today’s digitised world

The Washington State University neurological drug developer has gone public after issuing 12 million shares priced at $17 each.

The testing services provider hiked its overall funding to more than $68m in a round backed by Alibaba Hong Kong Entrepreneurs Fund.

Cash Capital was among the investors for Baijiayun, a Mooc platform whose shareholders also include Xiaodu Huyu, Huatu Education and BaishanCloud.

Chime has increased its valuation nearly tenfold in 18 months and is worth $14.5bn following a $485m series F round that included existing shareholder Access Industries.

Novartis-backed Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.

Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.

Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.

Telkom Indonesia and Go-Jek have thrown their weight behind Mobile Premier League’s latest funding round that will allow the esports platform to expand outside of India.

SymBiosis and Susquehanna International Group were among a consortium of new and existing backers that supplied $90m in series D financing to Finch Therapeutics.

Tencent has led a $64m series D round for the healthtech developer, whose shareholders already include SoftBank.